Gene expression in mixed type liposarcoma

Pathology

Volumn 38, Issue 2, 2006, Pages 114-119

  Jeung, Il Kim ^a   Choi, Kyung Un ^a   In, Sook Lee ^a   Tae, Yong Moon ^a   Chang, Hun Lee ^a   Hwal, Woong Kim ^a   Jee, Yeon Kim ^a   Do, Youn Park ^a   Mee, Young Sol ^a  

^a Pusan National University   (South Korea)

Author keywords

cDNA microarray; Gene expression; Mixed type liposarcoma

Indexed keywords

COMPLEMENTARY DNA; KI 67 ANTIGEN; PROTEIN MDM2; PROTEIN P53; PROTEIN S 100;

ADIPOSE TISSUE; AGED; ARTICLE; CANCER SIZE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CLINICAL FEATURE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME STRUCTURE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPOBLASTOMA; LIPOSARCOMA; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLEOMORPHIC ADENOMA; SIGNAL TRANSDUCTION; TISSUE SECTION;

ADIPOSE TISSUE; AGED; DNA, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOSARCOMA; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645540518     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020600557078     Document Type: Article

References (39)

1. Fletcher CDM, Unni KK, Mertens F. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon: IARC Press, 2002; 35-46.
2. Meis-Kindblom JM, Sjogren H, Kindblom LG, et al. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: Recognition of new variants and differential diagnosis. Virchows Arch 2001; 439: 141-51.
3. th ed. St Louis: Mosby, 2001; Chapter 17, Liposarcoma.
4. Mentzel T, Fletcher CDM. Dedifferentiated myxoid liposarcoma: A clinico-pathological study suggesting a closer relationship between myxoid and well differentiated liposarcoma. Histopathology 1997; 30: 457-63.
5. Klimstra DS, Moran CA, Perino G, et al. Liposarcoma of the anterior mediastinum and thymus. A clinicopathologic study of 28 cases. Am J Surg Pathol 1995; 19: 782-91.
6. Tan GY, Chong YL, Ramesh K, et al. Giant mixed-type perinephric liposarcoma. Int Urol Nephrol 2004; 36: 319-22.
7. Irie T, Hatori M, Watanabe M, et al. Radiologically and histologically mixed liposarcoma: A report of two biphasic cases. Jpn J Clin Oncol 2003; 33: 482-5.
8. De Cecco L, Gariboldi M, Reid JF, et al. Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcript. Histopathology 2005; 46: 334-41.
9. Nakanishi H, Araki N, Joyama S, et al. Myxoid liposarcoma with adipocytic maturation: Detection of TLS/CHOP fusion gene transcript. Diagn Mol Pathol 2004; 13: 92-6.
10. Shimoji T, Kanda H, Kitagawa T, et al. Clinico-molecular study of dedifferentiation in well-differentiated liposarcoma. Biochem Biophys Res Commun 2004; 314: 1133-40.
11. Skubitz KM, Cheng EY, Clohisy DR, et al. Differential gene expression in liposarcoma, lipoma, and adipose tissue. Cancer Invest 2005; 23: 105-18.
12. Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 2003; 100: 10393-8.
13. Hegde P, Qi R, Gaspard R, et al. Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res 2001; 61: 7792-7.
14. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
15. Tallini G, Akerman M, Dal Cin P, et al. Combined morphologic and karyotypic study of 28 myxoid liposarcomas. implications for a revised morphologic typing (a report from the CHAMP group). Am J Surg Pathol 1996; 20: 1047-55.
16. Gebhard S, Coindre JM, Michels JJ, et al. Pleomorphic liposarcoma: Clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: A study from the french federation of cancer centers sarcoma group. Am J Surg Pathol 2002; 26: 601-16.
17. Hashimoto H, Daimaru Y, Enjoji M. S-100 protein distribution in liposarcoma. an immunoperoxidase study with special reference to the distinction of liposarcoma from myxoid malignant fibrous histiocytoma. Virchows Arch A Pathol Anat Histopathol 1984; 405: 1-10.
18. Pilotti S, Delia Torre G, Lavarino C, et al. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: Implications for different pathogenetic mechanisms. J Pathol 1997; 181: 14-24.
19. Dei Tos AP, Doglioni C, Piccinin S, et al. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma. J Pathol 1997; 181: 8-13.
20. Tamborini E, Della Torre G, Lavarino C, et al. Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas. Int J Cancer 2001; 92: 790-6.
21. Vider BZ, Zimber A, Hirsch D, et al. Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem Biophys Res Commun 1997; 232: 742-8.
22. Xia X, Cheng A, Lessor T, et al. Ebp1, an ErbB-3 binding protein, interacts with rb and affects rb transcriptional regulation. J Cell Physiol 2001; 187: 209-17.
23. Idbaih A, Coindre JM, Derre J, et al. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest 2005; 85: 176-81.
24. Rieker RJ, Joos S, Bartsch C, et al. Distinct chromosomal imbalances in pleomorphic and in high-grade dedifferentiated liposarcomas. Int J Cancer 2002; 99: 68-73.
25. Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002; 99: 520-8.
26. Kato N, Fukase M, Motoyama T. Expression of a transcription factor, SOX9, in sertoli-stromal cell tumors of the ovary. Int J Gynecol Pathol 2004; 23: 180-1.
27. Abe N, Watanabe T, Izumisato Y, et al. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: Its potential use in the diagnosis of liver neoplasms. J Gastroenterol 2003; 38: 1144-9.
28. Pierantoni GM, Battista S, Pentimalli F, et al. A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: A model of human lipomas. Carcinogenesis 2003; 24: 1861-9.
29. Allenspach EJ, Maillard I, Aster JC, et al. Notch signaling in cancer. Cancer Biol Ther 2002; 1: 466-76.
30. Wen CY, Nakayama T, Wang AP, et al. Expression of pituitary tumor transforming gene in human gastric carcinoma. World J Gastroenterol 2004; 10: 481-3.
31. Aggarwal BB, Bhardwaj A, Aggarwal RS, et al. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 2004; 24: 2783-840.
32. Das R, Hammamieh R, Neill R, et al. Expression pattern of fatty acid-binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res 2001; 7: 1706-15.
33. Kubista B, Erovic BM, Klinger H, et al. CD9 expression is not a prognostic factor in human osteosarcoma. Cancer Lett 2004; 209: 105-10.
34. Bassi DE, Mahloogi H, Lopez De Cicco R, et al. Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. Am J Pathol 2003; 162: 439-47.
35. Forough R, Lindner L, Partridge C, et al. Elevated 80K-H protein in breast cancer: A role for FGF-1 stimulation of 80K-H. Int J Biol Markers 2003; 18: 89-98.
36. Brennan PA, Jing J, Ethunandan M, et al. Dystroglycan complex in cancer. Eur J Surg Oncol 2004; 30: 589-92.
37. Barthlen W, Flaadt D, Girgert R, et al. Significance of heparin-binding growth factor expression on cells of solid pediatric tumors. J Pediatr Surg 2003; 38: 1296-304.
38. Ishikawa M, Kitayama J, Kazama S, et al. The expression pattern of vascular endothelial growth factor C and D in human esophageal normal mucosa, dysplasia and neoplasia. Hepatogastroenterology 2004; 51: 1319-22.
39. Douglas ML, Richardson MM, Nicol DL. Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma. Cancer 2004; 100: 2118-24.